Cargando…

Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy

OBJECTIVE: To evaluate the occurrence of vitreous haemorrhage (VH) secondary to proliferative diabetic retinopathy (PDR) and the efficacy of intravitreal bevacizumab (IVB) for VH in 5-year real-life data. METHODS AND ANALYSIS: 850 adult patients with type 1 (T1D) or type 2 diabetes (T2D) with PDR we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wirkkala, Joonas, Bloigu, Risto, Hautala, Nina Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936487/ https://www.ncbi.nlm.nih.gov/pubmed/31909195 http://dx.doi.org/10.1136/bmjophth-2019-000390

Ejemplares similares

Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy
por: El-Batarny, Ashraf M
Publicado: (2007)

Early Vitreous Hemorrhage after Vitrectomy with Preoperative Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
por: Sato, Tatsuhiko, et al.
Publicado: (2013)

Effect of intravitreal triamcinolone acetonide injection at the end of vitrectomy for vitreous haemorrhage related to proliferative diabetic retinopathy
por: Takamura, Yoshihiro, et al.
Publicado: (2018)

Infographic: intravitreous aflibercept vs vitrectomy with panretinal photocoagulation for vitreous haemorrhage from proliferative diabetic retinopathy
por: Song, Anna, et al.
Publicado: (2021)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
por: Ribeiro de Carvalho, Giuliana, et al.
Publicado: (2020)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008)

Intravitreal Bevacizumab in Vitreous Hemorrhage and Diabetes Mellitus
por: Joob, Beuy, et al.
Publicado: (2017)

The adjunctive use of pre-operative intravitreal bevacizumab in the setting of proliferative diabetic retinopathy
por: Al-Kharashi, Abdullah, et al.
Publicado: (2016)

Intravitreal bevacizumab prior to vitrectomy for proliferative diabetic retinopathy: a systematic review
por: Dervenis, Panagiotis, et al.
Publicado: (2021)

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects
por: Alagöz, Cengiz, et al.
Publicado: (2016)

Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial
por: Jorge, Danilo Moyses, et al.
Publicado: (2021)

Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy
por: Chernykh, VV, et al.
Publicado: (2015)

Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study
por: Wirkkala, Joonas, et al.
Publicado: (2022)

Characterisation of the vitreous proteome in proliferative diabetic retinopathy
por: Wang, Hao, et al.
Publicado: (2012)

The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage
por: Li, Shengguo, et al.
Publicado: (2022)

Postvitrectomy diabetic vitreous hemorrhage in proliferative diabetic retinopathy
por: Shi, Lei, et al.
Publicado: (2012)

Vitreous changes after intravitreal bevacizumab monotherapy for retinopathy of prematurity: a case series
por: Shoeibi, Nasser, et al.
Publicado: (2018)

Retro-mode imaging of fibrovascular membrane in proliferative diabetic retinopathy after intravitreal bevacizumab injection
por: Suzuma, Kiyoshi, et al.
Publicado: (2011)

Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy
por: Chung, Eun Jee, et al.
Publicado: (2011)

Effects of an Intravitreal Bevacizumab Injection Combined With Panretinal Photocoagulation on High-Risk Proliferative Diabetic Retinopathy
por: Shin, Yong Woon, et al.
Publicado: (2009)

Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy
por: Fernando Arevalo, J.
Publicado: (2013)

Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy
por: Demir, Mehmet, et al.
Publicado: (2013)

Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy
por: Mandava, Nikhil, et al.
Publicado: (2020)

Plasma and Vitreous Metabolomics Profiling of Proliferative Diabetic Retinopathy
por: Wang, Hanying, et al.
Publicado: (2022)

Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy
por: Loporchio, Dean F., et al.
Publicado: (2021)

Effect of intravitreal conbercept injection on VEGF-A and -B levels in the aqueous and vitreous humor of patients with proliferative diabetic retinopathy
por: Zhang, Yunda, et al.
Publicado: (2021)

Macular Edema Formation and Deterioration of Retinal Function after Intravitreal Bevacizumab Injection for Proliferative Diabetic Retinopathy
por: Imai, Hisanori, et al.
Publicado: (2011)

Identification of Chemokines and Growth Factors in Proliferative Diabetic Retinopathy Vitreous
por: Dai, Ying, et al.
Publicado: (2014)

Eicosanoid Profiles in the Vitreous Humor of Patients with Proliferative Diabetic Retinopathy
por: Lin, Albert L, et al.
Publicado: (2020)

Vitreous hemorrhage in diabetes patients with proliferative diabetic retinopathy undergoing hemodialysis
por: Kameda, Yusuke, et al.
Publicado: (2019)

Single-dose Intravitreal Bevacizumab after Complete Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: an Effective Adjunctive Treatment
por: DEHGHANI, Alireza, et al.
Publicado: (2017)

Role of combined phacoemulsification and intravitreal injection of bevacizumab in prevention of postoperative macular edema in non-proliferative diabetic retinopathy
por: Khodabandeh, Alireza, et al.
Publicado: (2018)

Effect of Intravitreal Bevacizumab Injection before Panretinal Photocoagulation on the Prevention of Macular Edema Aggravation in Proliferative Diabetic Retinopathy
por: Choi, Wungrak, et al.
Publicado: (2020)

Multiple factors in the prediction of risk of recurrent vitreous haemorrhage after sutureless vitrectomy for non-clearing vitreous haemorrhage in patients with diabetic retinopathy
por: Ding, Yuhua, et al.
Publicado: (2020)

Angiogenic and Vasculogenic Factors in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Elevated vitreous Lipocalin-2 levels of patients with proliferative diabetic retinopathy
por: Wang, Hui, et al.
Publicado: (2020)

Correlation of Complement Activation in Aqueous and Vitreous in Patients With Proliferative Diabetic Retinopathy
por: Smith, Jesse M., et al.
Publicado: (2022)

Exosomal miRNA Profiling in Vitreous Humor in Proliferative Diabetic Retinopathy
por: Kot, Agnieszka, et al.
Publicado: (2022)

Factors correlated with visual outcomes at two and four years after vitreous surgery for proliferative diabetic retinopathy
por: Nishi, Katsuhiro, et al.
Publicado: (2021)

Intravitreal Bevacizumab May Increase Diabetic Macular Edema in Eyes with Attached Posterior Vitreous
por: Ozsutcu, Mustafa, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3upq0el41gtn61tcu24f43f8s7